{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:51:11Z","timestamp":1793033471040,"version":"4.5.0"},"reference-count":72,"publisher":"Japan Neurosurgical Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2022,6,15]]},"DOI":"10.2176\/jns-nmc.2022-0018","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T22:11:30Z","timestamp":1650579090000},"page":"261-269","source":"Crossref","is-referenced-by-count":40,"title":["Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies"],"prefix":"10.2176","volume":"62","author":[{"given":"Ryuta","family":"NAKAE","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"MURAI","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"MORITA","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"YOKOBORI","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Epstein DS, Mitra B, O&apos;Reilly G, Rosenfeld JV, Cameron PA: Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: a systematic review and meta-analysis. <i>Injury<\/i> 45: 819-824, 2014","DOI":"10.1016\/j.injury.2014.01.011"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI: Coagulation disorders after traumatic brain injury. <i>Acta Neurochir (Wien)<\/i> 150: 165-175, 2008","DOI":"10.1007\/s00701-007-1475-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wafaisade A, Lefering R, Tjardes T, et al.: Acute coagulopathy in isolated blunt traumatic brain injury. <i>Neurocrit Care<\/i> 12: 211-219, 2010","DOI":"10.1007\/s12028-009-9281-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Allard CB, Scarpelini S, Rhind SG, et al.: Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. <i>J Trauma<\/i> 67: 959-967, 2009","DOI":"10.1097\/TA.0b013e3181ad5d37"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kurland D, Hong C, Aarabi B, Gerzanich V, Simard JM: Hemorrhagic progression of a contusion after traumatic brain injury: a review. <i>J Neurotrauma<\/i> 29: 19-31, 2012","DOI":"10.1089\/neu.2011.2122"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Stein SC, Spettell C, Young G, Ross SE: Delayed and progressive brain injury in closed-head trauma: radiological demonstration. <i>Neurosurgery<\/i> 32: 25-30, 1993","DOI":"10.1097\/00006123-199301000-00004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Maegele M, Sch\u00f6chl H, Menovsky T, et al.: Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. <i>Lancet Neurol<\/i> 16: 630-647, 2017","DOI":"10.1016\/S1474-4422(17)30197-7"},{"key":"8","unstructured":"8) Franklyn M, Stemper BD (eds): Abbreviated Injury Scale (AIS) 2005 Update 2008. Des Plaines, IL, Association for the Advancement of Automotive Medicine, 2008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Goodnight SH, Kenoyer G, Rapaport SI, Patch MJ, Lee JA, Kurze T: Defibrination after brain-tissue destruction: a serious complication of head injury. <i>N Engl J Med<\/i> 290: 1043-1047, 1974","DOI":"10.1056\/NEJM197405092901903"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Keimowitz RM, Annis BL: Disseminated intravascular coagulation associated with massive brain injury. <i>J Neurosurg<\/i> 39: 178-180, 1973","DOI":"10.3171\/jns.1973.39.2.0178"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Gando S, Wada H, Thachil J, Scientific, Standardization Committee on DICotISoT, Haemostasis: Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT\/ACOTS). <i>J Thromb Haemost<\/i> 11: 826-835, 2013","DOI":"10.1111\/jth.12190"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kushimoto S, Shibata Y, Yamamoto Y: Implications of fibrinogenolysis in patients with closed head injury. <i>J Neurotrauma<\/i> 20: 357-363, 2003","DOI":"10.1089\/089771503765172318"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wada T, Gando S, Maekaw K, et al.: Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury. <i>Crit Care<\/i> 21: 219, 2017","DOI":"10.1186\/s13054-017-1808-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Briggs A, Gates JD, Kaufman RM, Calahan C, Gormley WB, Havens JM: Platelet dysfunction and platelet transfusion in traumatic brain injury. <i>J Surg Res<\/i> 193: 802-806, 2015","DOI":"10.1016\/j.jss.2014.08.016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Riojas CM, Ekaney ML, Ross SW, et al.: Platelet dysfunction after traumatic brain injury: a review. <i>J Neurotrauma<\/i> 38: 819-829, 2021","DOI":"10.1089\/neu.2020.7301"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Castellino FJ, Chapman MP, Donahue DL, et al.: Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. <i>J Trauma Acute Care Surg<\/i> 76: 1169-1176, 2014","DOI":"10.1097\/TA.0000000000000216"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Davis PK, Musunuru H, Walsh M, et al.: Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. <i>Neurocrit Care<\/i> 18: 201-208, 2013","DOI":"10.1007\/s12028-012-9745-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Amara U, Flierl MA, Rittirsch D, et al.: Molecular intercommunication between the complement and coagulation systems. <i>J Immunol<\/i> 185: 5628-5636, 2010","DOI":"10.4049\/jimmunol.0903678"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Foley JH, Conway EM: Cross talk pathways between coagulation and inflammation. <i>Circ Res<\/i> 118: 1392-1408, 2016","DOI":"10.1161\/CIRCRESAHA.116.306853"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nakae R, Takayama Y, Kuwamoto K, Naoe Y, Sato H, Yokota H: Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. <i>J Neurotrauma<\/i> 33: 688-695, 2016","DOI":"10.1089\/neu.2015.4039"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hukkelhoven CW, Steyerberg EW, Rampen AJ, et al.: Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. <i>J Neurosurg<\/i> 99: 666-673, 2003","DOI":"10.3171\/jns.2003.99.4.0666"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nakae R, Fujiki Y, Takayama Y, et al.: Age-related differences in the time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. <i>Int J Mol Sci<\/i> 21, 2020","DOI":"10.3390\/ijms21165613"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nakae R, Fujiki Y, Takayama Y, et al.: Time course of coagulation and fibrinolytic parameters in pediatric traumatic brain injury. <i>J Neurosurg Pediatr<\/i> 28: 526-532, 2021","DOI":"10.3171\/2021.5.PEDS21125"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Juratli TA, Zang B, Litz RJ, et al.: Early hemorrhagic progression of traumatic brain contusions: frequency, correlation with coagulation disorders, and patient outcome: a prospective study. <i>J Neurotrauma<\/i> 31: 1521-1527, 2014","DOI":"10.1089\/neu.2013.3241"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tian HL, Chen H, Wu BS, et al.: D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases. <i>Neurosurg Rev<\/i> 33: 359-365, 2010","DOI":"10.1007\/s10143-010-0251-z"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Yokota H, Naoe Y, Nakabayashi M, et al.: Cerebral endothelial injury in severe head injury: the significance of measurements of serum thrombomodulin and the von Willebrand factor. <i>J Neurotrauma<\/i> 19: 1007-1015, 2002","DOI":"10.1089\/089771502760341929"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yuan Q, Sun YR, Wu X, et al.: Coagulopathy in traumatic brain injury and its correlation with progressive hemorrhagic injury: a systematic review and meta-analysis. <i>J Neurotrauma<\/i> 33: 1279-1291, 2016","DOI":"10.1089\/neu.2015.4205"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M: Early coagulopathy predicts mortality in trauma. <i>J Trauma<\/i> 55: 39-44, 2003","DOI":"10.1097\/01.TA.0000075338.21177.EF"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sun Y, Wang J, Wu X, et al.: Validating the incidence of coagulopathy and disseminated intravascular coagulation in patients with traumatic brain injury-analysis of 242 cases. <i>Br J Neurosurg<\/i> 25: 363-368, 2011","DOI":"10.3109\/02688697.2011.552650"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Van Beek JG, Mushkudiani NA, Steyerberg EW, et al.: Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT study. <i>J Neurotrauma<\/i> 24: 315-328, 2007","DOI":"10.1089\/neu.2006.0034"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Greuters S, van den Berg A, Franschman G, et al.: Acute and delayed mild coagulopathy are related to outcome in patients with isolated traumatic brain injury. <i>Crit Care<\/i> 15: R2, 2011","DOI":"10.1186\/cc9399"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Takahashi H, Urano T, Takada Y, Nagai N, Takada A: Fibrinolytic parameters as an admission prognostic marker of head injury in patients who talk and deteriorate. <i>J Neurosurg<\/i> 86: 768-772, 1997","DOI":"10.3171\/jns.1997.86.5.0768"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lobato RD, Rivas JJ, Gomez PA, et al.: Head-injured patients who talk and deteriorate into coma. Analysis of 211 cases studied with computerized tomography. <i>J Neurosurg<\/i> 75: 256-261, 1991","DOI":"10.3171\/jns.1991.75.2.0256"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Marshall LF, Toole BM, Bowers SA: The National Traumatic Coma Data Bank. Part 2: patients who talk and deteriorate: implications for treatment. <i>J Neurosurg<\/i> 59: 285-288, 1983","DOI":"10.3171\/jns.1983.59.2.0285"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ratanalert S, Chompikul J, Hirunpat S: Talked and deteriorated head injury patients: how many poor outcomes can be avoided? <i>J Clin Neurosci<\/i> 9: 640-643, 2002","DOI":"10.1054\/jocn.2002.1085"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Goldschlager T, Rosenfeld JV, Winter CD:  &quot;Talk and die&quot; patients presenting to a major trauma centre over a 10 year period: a critical review. <i>J Clin Neurosci<\/i> 14: 618-623, 2007","DOI":"10.1016\/j.jocn.2006.02.018"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U: Enzyme-controlling medicines: introduction. <i>Semin Thromb Hemost<\/i> 23: 493-501, 1997","DOI":"10.1055\/s-2007-996127"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) CRASH-2 trial collaborators, Shakur H, Roberts I, et al.: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. <i>Lancet<\/i> 376: 23-32, 2010","DOI":"10.1016\/S0140-6736(10)60835-5"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Gayet-Ageron A, Prieto-Merino D, Ker K, et al.: Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. <i>Lancet<\/i> 391: 125-132, 2018","DOI":"10.1016\/S0140-6736(17)32455-8"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Ker K, Roberts I, Shakur H, Coats TJ: Antifibrinolytic drugs for acute traumatic injury. <i>Cochrane Database Syst Rev<\/i> CD004896, 2015","DOI":"10.1002\/14651858.CD004896.pub4"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Shiraishi A, Kushimoto S, Otomo Y, et al.: Effectiveness of early administration of tranexamic acid in patients with severe trauma. <i>Br J Surg<\/i> 104: 710-717, 2017","DOI":"10.1002\/bjs.10497"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) CRASH-3 trial collaborators: Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. <i>Lancet<\/i> 394: 1713-1723, 2019","DOI":"10.1016\/S0140-6736(19)32233-0"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Hiippala ST, Myllyla GJ, Vahtera EM: Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. <i>Anesth Analg<\/i> 81: 360-365, 1995","DOI":"10.1097\/00000539-199508000-00026"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Rourke C, Curry N, Khan S, et al.: Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. <i>J Thromb Haemost<\/i> 10: 1342-1351, 2012","DOI":"10.1111\/j.1538-7836.2012.04752.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Mosesson MW: Fibrinogen and fibrin structure and functions. <i>J Thromb Haemost<\/i> 3: 1894-1904, 2005","DOI":"10.1111\/j.1538-7836.2005.01365.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) S\u00f8rensen B, Larsen OH, Rea CJ, Tang M, Foley JH, Fenger-Eriksen C: Fibrinogen as a hemostatic agent. <i>Semin Thromb Hemost<\/i> 38: 268-273, 2012","DOI":"10.1055\/s-0032-1309287"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Cannon JW, Khan MA, Raja AS, et al.: Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the Eastern Association for the Surgery of Trauma. <i>J Trauma Acute Care Surg<\/i> 82: 605-617, 2017","DOI":"10.1097\/TA.0000000000001333"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Spahn DR, Bouillon B, Cerny V, et al.: The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. <i>Crit Care<\/i> 23: 98, 2019","DOI":"10.1186\/s13054-019-2347-3"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Anglin CO, Spence JS, Warner MA, et al.: Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. <i>J Neurosurg<\/i> 118: 676-686, 2013","DOI":"10.3171\/2012.11.JNS12622"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B: The effect of fresh frozen plasma in severe closed head injury. <i>Clin Neurol Neurosurg<\/i> 109: 166-171, 2007","DOI":"10.1016\/j.clineuro.2006.09.001"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Winter JP, Plummer D, Bottini A, Rockswold GR, Ray D: Early fresh frozen plasma prophylaxis of abnormal coagulation parameters in the severely head-injured patient is not effective. <i>Ann Emerg Med<\/i> 18: 553-555, 1989","DOI":"10.1016\/S0196-0644(89)80842-X"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Zhang LM, Li R, Zhao XC, Zhang Q, Luo XL: Increased transfusion of fresh frozen plasma is associated with mortality or worse functional outcomes after severe traumatic brain injury: a retrospective study. <i>World Neurosurg<\/i> 104: 381-389, 2017","DOI":"10.1016\/j.wneu.2017.04.140"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Nakae R, Yokobori S, Takayama Y, et al.: A retrospective study of the effect of fibrinogen levels during fresh frozen plasma transfusion in patients with traumatic brain injury. <i>Acta Neurochir (Wien)<\/i> 161: 1943-1953, 2019","DOI":"10.1007\/s00701-019-04010-3"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE: Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. <i>JAMA Surg<\/i> 148: 218-225, 2013","DOI":"10.1001\/jamasurg.2013.764"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Holcomb JB, Fox EE, Zhang X, et al.: Cryoprecipitate use in the PROMMTT study. <i>J Trauma Acute Care Surg<\/i> 75: S31-39, 2013","DOI":"10.1097\/TA.0b013e31828fa3ed"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Wafaisade A, Lefering R, Maegele M, et al.: Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. <i>J Trauma Acute Care Surg<\/i> 74: 387-383, 2013","DOI":"10.1097\/TA.0b013e31827e2410"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Innerhofer P, Fries D, Mittermayr M, et al.: Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. <i>Lancet Haematol<\/i> 4: e258-e271, 2017","DOI":"10.1016\/S2352-3026(17)30077-7"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Stabler SN, Li SS, Karpov A, Vu EN: Use of fibrinogen concentrate for trauma-related bleeding: A systematic-review and meta-analysis. <i>J Trauma Acute Care Surg<\/i> 89: 1212-1224, 2020","DOI":"10.1097\/TA.0000000000002920"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Shibahashi K, Nishimura S, Sugiyama K, Hoda H, Hamabe Y, Fujita H: Initial Results of empirical cryoprecipitate transfusion in the treatment of isolated severe traumatic brain injury: use of in-house-produced cryoprecipitate. <i>Neurol Med Chir (Tokyo)<\/i> 59: 371-378, 2019","DOI":"10.2176\/nmc.oa.2019-0062"},{"key":"60","unstructured":"60) Sugiyama K, Fujita H, Nishimura S: Effects of in-house cryoprecipitate on transfusion usage and mortality in patients with multiple trauma with severe traumatic brain injury: a retrospective cohort study. <i>Blood Transfus<\/i> 18: 6-12, 2020"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Sch\u00f6chl H, Solomon C, Traintinger S, et al.: Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. <i>J Neurotrauma<\/i> 28: 2033-2041, 2011","DOI":"10.1089\/neu.2010.1744"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Boffard KD, Riou B, Warren B, et al.: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. <i>J Trauma<\/i> 59: 8-15, 2005","DOI":"10.1097\/01.TA.0000171453.37949.B7"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Hauser CJ, Boffard K, Dutton R, et al.: Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. <i>J Trauma<\/i> 69: 489-500, 2010","DOI":"10.1097\/TA.0b013e3181edf36e"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Yank V, Tuohy CV, Logan AC, et al.: Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. <i>Ann Intern Med<\/i> 154: 529-540, 2011","DOI":"10.7326\/0003-4819-154-8-201104190-00004"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Lombardo S, Millar D, Jurkovich GJ, Coimbra R, Nirula R: Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis. <i>Trauma Surg Acute Care Open<\/i> 3: e000134, 2018","DOI":"10.1136\/tsaco-2017-000134"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Yuan Q, Wu X, Du ZY, et al.: Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury. <i>J Crit Care<\/i> 30: 116-120, 2015","DOI":"10.1016\/j.jcrc.2014.07.009"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) O&apos;Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM: Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. <i>JAMA<\/i> 295: 293-298, 2006","DOI":"10.1001\/jama.295.3.293"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Jehan F, Aziz H, O&apos;Keeffe T, et al.: The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: A propensity matched analysis. <i>J Trauma Acute Care Surg<\/i> 85: 18-24, 2018","DOI":"10.1097\/TA.0000000000001938"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Schn\u00fcriger B, Inaba K, Abdelsayed GA, et al.: The impact of platelets on the progression of traumatic intracranial hemorrhage. <i>J Trauma<\/i> 68: 881-885, 2010","DOI":"10.1097\/TA.0b013e3181d3cc58"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Gonzalez E, Moore EE, Moore HB, et al.: Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. <i>Ann Surg<\/i> 263: 1051-1059, 2016","DOI":"10.1097\/SLA.0000000000001608"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Baksaas-Aasen K, Gall LS, Stensballe J, et al.: Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. <i>Intensive Care Med<\/i> 47: 49-59, 2021","DOI":"10.1007\/s00134-020-06266-1"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Cannon JW, Dias JD, Kumar MA, et al.: Use of thromboelastography in the evaluation and management of patients with traumatic brain injury: a systematic review and meta-analysis. <i>Crit Care Explor<\/i> 3: e0526, 2021","DOI":"10.1097\/CCE.0000000000000526"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/62\/6\/62_2022-0018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T04:54:35Z","timestamp":1655528075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/62\/6\/62_2022-0018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2022-0018","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"article-number":"2022-0018"}}